Cargando…

Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results

BACKGROUND: To evaluate the efficacy of first-line bevacizumab-based chemotherapy for untreated metastatic colorectal cancer (mCRC) based on age. METHODS: Eligibility criteria focused on M1 disease without prior palliative chemotherapy. Choice of chemotherapy regimen was at the physician’s discretio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofheinz, Ralf, Petersen, Volker, Kindler, Manfred, Schulze, Mathias, Seraphin, Joerg, Hoeffkes, Heinz-Gert, Valdix, Anette-R, Schroeder, Jan, Herrenberger, Julia, Stein, Alexander, Hinke, Axel, Arnold, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198800/ https://www.ncbi.nlm.nih.gov/pubmed/25311943 http://dx.doi.org/10.1186/1471-2407-14-761

Ejemplares similares

Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
por: Stein, Alexander, et al.
Publicado: (2016)

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
por: Hoehler, T, et al.
Publicado: (2013)

CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer
por: Sandra-Petrescu, Flavius, et al.
Publicado: (2015)

Child Abuse Potential in Young German Parents: Predictors, Associations with Self-reported Maltreatment and Intervention Use
por: Lang, Katrin, et al.
Publicado: (2021)

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer
por: Gorbunova, Vera, et al.
Publicado: (2018)

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer
por: Gorbunova, Vera, et al.
Publicado: (2019)

AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer
por: Kripp, Melanie, et al.
Publicado: (2017)

HER2 testing in gastric cancer: results of a German expert meeting
por: Lordick, Florian, et al.
Publicado: (2017)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials
por: Goey, Kaitlyn K H, et al.
Publicado: (2017)

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial
por: Giessen, Clemens, et al.
Publicado: (2011)

Validation of the German Diabetes Risk Score among the general adult population: findings from the German Health Interview and Examination Surveys
por: Paprott, Rebecca, et al.
Publicado: (2016)

Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer
por: Loupakis, Fotios, et al.
Publicado: (2018)

Detection of methadone and buprenorphine in urine samples from inmates of German prisons
por: Franchetti, Giorgia, et al.
Publicado: (2023)

Dictionary of radiological engineering: English-German-French, German-English-French, French-German-English
por: Neuder, Gustav F, et al.
Publicado: (1973)

Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer
por: Müller, Volkmar, et al.
Publicado: (2010)

MYL-1402O: A Bevacizumab Biosimilar
por: Lee, Arnold
Publicado: (2021)

Data systems dictionary: German-English, English-German
por: Schmidt, Rudolf, et al.
Publicado: (1985)

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial
por: Stein, Alexander, et al.
Publicado: (2013)

SLiM CRAB criteria revisited: temporal trends in prognosis of patients with smoldering multiple myeloma who meet the definition of ‘biomarker-defined early multiple myeloma’—a systematic review with meta-analysis
por: Ludwig, Heinz, et al.
Publicado: (2023)

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
por: Heinemann, Volker, et al.
Publicado: (2008)

Correction to: MYL-1402O: A Bevacizumab Biosimilar
por: Lee, Arnold
Publicado: (2022)

Annual International Conference of the German Operations Research Society (GOR) University of Augsburg
por: Fleischmann, Bernhard, et al.
Publicado: (2009)

Risks of pregnancy and birth in obese primiparous women: an analysis of German perinatal statistics
por: Briese, Volker, et al.
Publicado: (2010)

Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A
por: Burgermeister, Elke, et al.
Publicado: (2019)

Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
por: Ludwig, Heinz, et al.
Publicado: (2020)

Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2015)

Obesity in pregnant women: a 20-year analysis of the German experience
por: Strauss, Alexander, et al.
Publicado: (2021)

Survey on the risk awareness of german pig and cattle farmers in relation to dealing with MRSA and antibiotics
por: Schulze-Geisthövel, Sophia Veronika, et al.
Publicado: (2016)

A NEW INSTRUMENT TO DETERMINE ADEQUATE STAFFING RATIOS IN GERMAN NURSING HOMES
por: Wolf-Ostermann, Karin, et al.
Publicado: (2019)

Biased emotional attention in patients with dental phobia
por: Alexopoulos, Johanna, et al.
Publicado: (2018)

ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
por: Fleischmann, Maximilian, et al.
Publicado: (2022)

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019)

Dietary Patterns in Primary School are of Prospective Relevance for the Development of Body Composition in Two German Pediatric Populations
por: Wolters, Maike, et al.
Publicado: (2018)

Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine
por: Kripp, Melanie, et al.
Publicado: (2008)

Overweight in Adolescence Can Be Predicted at Age 6 Years: A CART Analysis in German Cohorts
por: Riedel, Christina, et al.
Publicado: (2014)

Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study
por: Kraemer, Susanne, et al.
Publicado: (2013)

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
por: Arndt, Volker, et al.
Publicado: (2022)

Dysphonia after Bevacizumab Rechallenge: A Case Report
por: Carter, Corey A., et al.
Publicado: (2015)

The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß‐catenin signaling
por: Krug, Sebastian, et al.
Publicado: (2021)

Bevacizumab for glioblastoma
por: Narita, Yoshitaka
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g57f8g8qmde5s79r7cb97t622c